Medtronic Inc. has announced that it has received United States Food and Drug Administration (FDA) approval under a humanitarian device exemption (HDE) for the Medtronic Enterra II System. The system is used to treat chronic intractable nausea and vomiting associated with gastroparesis of diabetic or unknown origin when more conservative treatments fail or cannot be tolerated. Medtronic Enterra Therapy consists of a small medical device called ...Saturday 24 January 2015
Enhanced Therapy to Treat Symptoms of Serious Stomach Disorder
Medtronic Inc. has announced that it has received United States Food and Drug Administration (FDA) approval under a humanitarian device exemption (HDE) for the Medtronic Enterra II System. The system is used to treat chronic intractable nausea and vomiting associated with gastroparesis of diabetic or unknown origin when more conservative treatments fail or cannot be tolerated. Medtronic Enterra Therapy consists of a small medical device called ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment